{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:11:32Z","timestamp":1788901892392,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cca.2026.121203","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:23:14Z","timestamp":1782490994000},"page":"121203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quality assessment, prognostic factors, and biomarkers for brain tumor analysis: a comprehensive systematic review"],"prefix":"10.1016","volume":"592","author":[{"given":"P.","family":"Balaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Devasena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cca.2026.121203_bb0005","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/neuonc\/noaa077","article-title":"Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas","volume":"22","author":"Fukuoka","year":"2020","journal-title":"Neuro-Oncology"},{"issue":"16","key":"10.1016\/j.cca.2026.121203_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164172","article-title":"Brain tumor detection based on deep learning approaches and magnetic resonance imaging","volume":"15","author":"Abdusalomov","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121203_bb0015","series-title":"Graphs in Biomedical Image Analysis, Computational Anatomy and Imaging Genetics","first-page":"201","article-title":"Multi-modal image classification using low-dimensional texture features for genomic brain tumor recognition","author":"Alberts","year":"2017"},{"key":"10.1016\/j.cca.2026.121203_bb0020","series-title":"International MICCAI Brainlesion Workshop","first-page":"170","article-title":"Brain tumor detection and classification from multi-sequence MRI: study using ConvNets","author":"Banerjee","year":"2018"},{"issue":"8","key":"10.1016\/j.cca.2026.121203_bb0025","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/biomedicines10082030","article-title":"MGMT promoter methylation as a prognostic factor in primary glioblastoma: a single-institution observational study","volume":"10","author":"Szylberg","year":"2022","journal-title":"Biomedicines"},{"issue":"23","key":"10.1016\/j.cca.2026.121203_bb0030","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus Temozolomide vs Temozolomide alone for glioblastoma: A randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cca.2026.121203_bb0035","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1093\/neuros\/nyaa562","article-title":"MGMT-positive vs MGMT-negative patients with glioblastoma: identification of prognostic factors and resection threshold","volume":"88","author":"Katsigiannis","year":"2021","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-021-01863-0","article-title":"Comparison of content and psychometric properties for assessment tools used for brain tumor patients: a scoping review","volume":"19","author":"\u0122iga","year":"2021","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.cca.2026.121203_bb0045","series-title":"World Congress on Medical Physics and Biomedical Engineering","first-page":"183","article-title":"Brain tumor classification using convolutional neural network","author":"Abiwinanda","year":"2018"},{"issue":"12","key":"10.1016\/j.cca.2026.121203_bb0050","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.18.01765","article-title":"Conformal radiation therapy for Pediatric Ependymoma, chemotherapy for incompletely resected Ependymoma, and observation for completely resected, Supratentorial Ependymoma","volume":"37","author":"Merchant","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12883-020-01768-3","article-title":"Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report","volume":"20","author":"Hsu","year":"2020","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.cca.2026.121203_bb0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.cca.2026.121203_bb0065","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"11","key":"10.1016\/j.cca.2026.121203_bb0070","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/cncr.31995","article-title":"Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: cure at a cost","volume":"125","author":"Zapotocky","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-017-0443-7","article-title":"Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery","volume":"5","author":"Cimino","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.cca.2026.121203_bb0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7150\/jca.11975","article-title":"The prognostic significance of combining VEGFA, FLT1 and KDR mRNA expressions in brain tumors","volume":"6","author":"Zhang","year":"2015","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41568-019-0223-8","article-title":"Medulloblastomics revisited: biological and clinical insights from thousands of patients","volume":"20","author":"Hovestadt","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.cca.2026.121203_bb0090","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.31557\/APJCP.2020.21.11.3387","article-title":"Karnofsky performance scale and neurological assessment of Neuro-oncology scale as early predictor in glioma","volume":"21","author":"Gunawan","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.cca.2026.121203_bb0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmoldx.2018.09.003","article-title":"Development of novel mutation-specific droplet digital PCR assays detecting TERT promoter mutations in tumor and plasma samples","volume":"21","author":"Corless","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.cca.2026.121203_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s00138-021-01262-x","article-title":"An empirical study of different machine learning techniques for brain tumor classification and subsequent segmentation using hybrid texture feature","volume":"33","author":"Jena","year":"2022","journal-title":"Mach. Vis. Appl."},{"key":"10.1016\/j.cca.2026.121203_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920923432","article-title":"Secondary glioblastoma metastasis outside the central nervous system in a young HIV-infected patient","volume":"12","author":"Rodrigues","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.20892\/j.issn.2095-3941.2020.0179","article-title":"Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma","volume":"18","author":"Chai","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"13","key":"10.1016\/j.cca.2026.121203_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137039","article-title":"Molecular and circulating biomarkers of brain tumors","volume":"22","author":"Jelski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.cca.2026.121203_bb0120","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4155\/fmc-2018-0521","article-title":"Nanoformulations for glioblastoma multiforme: a new hope for treatment","volume":"11","author":"Ortiz","year":"2019","journal-title":"Future Med. Chem."},{"issue":"7","key":"10.1016\/j.cca.2026.121203_bb0125","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.18632\/oncotarget.14406","article-title":"CD133 in brain tumor: the prognostic factor","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-020-01959-y","article-title":"Extracranial metastases in secondary glioblastoma multiforme: a case report","volume":"20","author":"Rossi","year":"2020","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0135","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7150\/jca.63595","article-title":"Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation","volume":"13","author":"Liu","year":"2022","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.cca.2026.121203_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nec.2020.12.007","article-title":"Novel radiation approaches","volume":"32","author":"Kotecha","year":"2021","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.cca.2026.121203_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00506","article-title":"Isocitrate dehydrogenase mutations in glioma: from basic discovery to therapeutics development","volume":"9","author":"Huang","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s40644-022-00455-5","article-title":"Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics","volume":"22","author":"Vagvala","year":"2022","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574892812666171129142023","article-title":"Brain Cancer: implication to disease, therapeutic strategies and tumor targeted drug delivery approaches","volume":"13","author":"Shah","year":"2018","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.cca.2026.121203_bb0160","series-title":"International MICCAI Brainlesion Workshop","first-page":"208","article-title":"Holistic brain tumor screening and classification based on densenet and recurrent neural network","author":"Zhou","year":"2018"},{"issue":"2","key":"10.1016\/j.cca.2026.121203_bb0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3892\/ijo.2015.3026","article-title":"Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (review)","volume":"47","author":"Cabrini","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.121203_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2015.09.002","article-title":"EGFR mutation promotes glioblastoma through epigenome and transcription factor network remodeling","volume":"60","author":"Liu","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cca.2026.121203_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8013575","article-title":"Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives","volume":"2017","author":"Szopa","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"21","key":"10.1016\/j.cca.2026.121203_bb0180","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.cca.2026.121203_bb0185","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/neuonc\/noz012","article-title":"Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications","volume":"21","author":"Boire","year":"2019","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.cca.2026.121203_bb0190","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1373\/clinchem.2017.283531","article-title":"RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients","volume":"64","author":"Keup","year":"2018","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.cca.2026.121203_bb0195","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1078-0432.CCR-15-1015","article-title":"Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2-amplified and TP53 wild-type glioblastomas","volume":"22","author":"Verreault","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cca.2026.121203_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123529","article-title":"Glioblastoma: relationship between metabolism and immunosuppressive microenvironment","volume":"10","author":"Hern\u00e1ndez","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.cca.2026.121203_bb0205","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/neuonc\/noab034","article-title":"Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q","volume":"23","author":"Baroni","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6511-6","article-title":"Prognostic factors of patients with gliomas - an analysis on 335 patients with glioblastoma and other forms of gliomas","volume":"20","author":"Liang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2026.121203_bb0215","doi-asserted-by":"crossref","first-page":"9032","DOI":"10.1109\/TIP.2020.3023609","article-title":"Exploring task structure for brain tumor segmentation from multi-modality MR images","volume":"29","author":"Zhang","year":"2020","journal-title":"IEEE Trans. Image Process."},{"issue":"6","key":"10.1016\/j.cca.2026.121203_bb0220","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-18-1892","article-title":"Genetic, epigenetic, and immunologic profiling of MMR-deficient relapsed glioblastoma","volume":"25","author":"Indraccolo","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121203_bb0225","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1517\/13543784.2012.703177","article-title":"Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions","volume":"21","author":"Patel","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"5","key":"10.1016\/j.cca.2026.121203_bb0230","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1109\/TMI.2016.2538465","article-title":"Brain tumor segmentation using convolutional neural networks in MRI images","volume":"35","author":"Pereira","year":"2016","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.cca.2026.121203_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00282","article-title":"Analyzing the quality and challenges of uncertainty estimations for brain tumor segmentation","volume":"14","author":"Jungo","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cca.2026.121203_bb0240","series-title":"Information Processing in Medical Imaging: 26th International Conference, IPMI 2019, Hong Kong, China, June 2\u20137, 2019, Proceedings 26","first-page":"3","article-title":"A bayesian neural net to segment images with uncertainty estimates and good calibration","author":"Jena","year":"2019"},{"key":"10.1016\/j.cca.2026.121203_bb0245","series-title":"Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries: 4th International Workshop, BrainLes 2018, Held in Conjunction with MICCAI 2018, Granada, Spain, September 16, 2018, Revised Selected Papers, Part II 4","first-page":"311","article-title":"3D MRI brain tumor segmentation using auto encoder regularization","author":"Myronenko","year":"2019"},{"issue":"7697","key":"10.1016\/j.cca.2026.121203_bb0250","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cca.2026.121203_bb0255","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41416-019-0603-6","article-title":"Circulating biomarkers in patients with glioblastoma","volume":"122","author":"M\u00fcller Bark","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"6122","key":"10.1016\/j.cca.2026.121203_bb0260","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121203_bb0265","article-title":"Loss of heterozygosity: what is it good for?","volume":"8","author":"Ryland","year":"2015","journal-title":"BMC Med. Genet."},{"issue":"2","key":"10.1016\/j.cca.2026.121203_bb0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11060-015-1978-8","article-title":"Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma","volume":"126","author":"Tichy","year":"2016","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12035-014-8993-1","article-title":"Serum MicroRNA-125b as a potential biomarker for glioma diagnosis","volume":"53","author":"Wei","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cca.2026.121203_bb0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-030-35805-1_2","article-title":"Epithelial-mesenchymal plasticity in circulating tumor cells, the precursors of metastasis","volume":"1220","author":"Burr","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cca.2026.121203_bb0285","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5625757","article-title":"Application of genetic algorithm and U-net in brain tumor segmentation and classification: a deep learning approach","volume":"2022","author":"Arif","year":"2022","journal-title":"Comput. Intell. Neurosci."},{"issue":"2","key":"10.1016\/j.cca.2026.121203_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020174","article-title":"Treatment of glioblastoma (GBM) with the addition of tumor-treating fields (TTF): a review","volume":"11","author":"Fabian","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121203_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2015.01.029","article-title":"Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy","volume":"132","author":"Iaccarino","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0300","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-08507-3","article-title":"Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases","volume":"12","author":"Kotecha","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cca.2026.121203_bb0305","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2018.04.045","article-title":"Combining perfusion and high B-value diffusion MRI to inform prognosis and predict failure patterns in glioblastoma","volume":"102","author":"Wahl","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cca.2026.121203_bb0310","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","article-title":"Extracellular vesicles in cancer \u2014 implications for future improvements in cancer care","volume":"15","author":"Xu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2026.121203_bb0315","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-019-02055-3","article-title":"An update on the central nervous system manifestations of Li-Fraumeni syndrome","volume":"139","author":"Orr","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.cca.2026.121203_bb0320","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","article-title":"A review of Von Hippel-Lindau syndrome","volume":"4","author":"Varshney","year":"2017","journal-title":"J. Kidney Cancer VHL"},{"issue":"8","key":"10.1016\/j.cca.2026.121203_bb0325","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/gutjnl-2016-312734","article-title":"TSC1\/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication","volume":"66","author":"Ho","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cca.2026.121203_bb0330","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2015.125","article-title":"Role of Merlin\/NF2 inactivation in tumor biology","volume":"35","author":"Petrilli","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2026.121203_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00056","article-title":"Neuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment","volume":"5","author":"Dwan","year":"2015","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2026.121203_bb0340","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1535-7163.MCT-23-0510","article-title":"MEK inhibition enhances the antitumor effect of radiotherapy in NF1-deficient glioblastoma","volume":"23","author":"Ioannou","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cca.2026.121203_bb0345","article-title":"Analysis of integrating PIK3CA and NF1 mutations into glioblastoma multiforme prognostication and immunotherapy treatment strategy","author":"Chen","year":"2024","journal-title":"Res. Square"},{"issue":"4","key":"10.1016\/j.cca.2026.121203_bb0350","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/2767-9764.CRC-24-0620","article-title":"Diverse ERBB2\/ERBB3 activating alterations and coalterations have implications for HER2\/3-targeted therapies across solid tumors","volume":"5","author":"Liu","year":"2025","journal-title":"Cancer Res. Commun."},{"issue":"224","key":"10.1016\/j.cca.2026.121203_bb0355","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.cca.2026.121203_bb0360","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/2159-8290.CD-14-0471","article-title":"Brain tumor cells in circulation are enriched for mesenchymal gene expression","volume":"4","author":"Sullivan","year":"2014","journal-title":"Cancer Discov."},{"issue":"7741","key":"10.1016\/j.cca.2026.121203_bb0365","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-019-0882-3","article-title":"Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid","volume":"565","author":"Miller","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121203_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cca.2026.121203_bb0375","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"issue":"suppl_3","key":"10.1016\/j.cca.2026.121203_bb0380","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy139.354","article-title":"P05.28 Karnofsky performance score of brain tumor patients depends on clinician status","volume":"20","author":"Frappaz","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1016\/j.cca.2026.121203_bb0385","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00401-020-02127-9","article-title":"cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas","volume":"139","author":"Brat","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.cca.2026.121203_bb0390","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nox141","article-title":"Pediatric low-grade gliomas: next biologically driven steps","volume":"20","author":"DTW","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10014-023-00474-5","article-title":"Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next","volume":"41","author":"Komori","year":"2024","journal-title":"Brain Tumor Pathol."},{"issue":"7","key":"10.1016\/j.cca.2026.121203_bb0400","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1373\/clinchem.2017.283531","article-title":"RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients","volume":"64","author":"Keup","year":"2018","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cca.2026.121203_bb0405","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/neuonc\/noab003","article-title":"PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma","volume":"23","author":"Wu","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"12","key":"10.1016\/j.cca.2026.121203_bb0410","first-page":"4134","article-title":"Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes","volume":"10","author":"Aili","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"7578","key":"10.1016\/j.cca.2026.121203_bb0415","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cca.2026.121203_bb0420","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-18-1941","article-title":"Clinical significance of extracellular vesicles in plasma from glioblastoma patients","volume":"25","author":"Osti","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cca.2026.121203_bb0425","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/07357907.2014.933237","article-title":"Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas","volume":"32","author":"Lange","year":"2014","journal-title":"Cancer Investig."},{"issue":"5","key":"10.1016\/j.cca.2026.121203_bb0430","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/09638288.2016.1145258","article-title":"Refinements of the ICF linking rules to strengthen their potential for establishing comparability of health information","volume":"41","author":"Cieza","year":"2019","journal-title":"Disabil. Rehabil."},{"issue":"8","key":"10.1016\/j.cca.2026.121203_bb0435","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/annonc\/mdx230","article-title":"Surgical resection versus watchful waiting in low-grade gliomas","volume":"28","author":"Jakola","year":"2017","journal-title":"Ann. Oncol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:48:26Z","timestamp":1788900506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126003852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":87,"alternative-id":["S0009898126003852"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121203","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality assessment, prognostic factors, and biomarkers for brain tumor analysis: a comprehensive systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121203"}}